Best Cancer Articles

Chelation (pronounced key-LAY-shun) is a process in which chemicals unite with minerals. It comes from the Greek chele, which means “claw.” Like a claw, a chelation agent will grab and chemically bond with minerals, metals or poisons. The process occurs naturally in a body (blood hemoglobin unites with iron and thus oxygen is provided to parts of the body). Man first created chelation agents during World War II to rid the body of toxic metals. Scientists synthesized a ring of molecules which encircled mineral molecules and eliminated them from the body.

As a generally recognized way of ridding the body of heavy metals and poisons, chelation agents are usually administered intravenously. Chelation agents or chelates locate toxins and form a bond with them. Thus the toxin is pulled off the cell it was attached to and washed out of the body. The drawback here is that the toxin is not neutralized in this method and has a chance to attach itself to other cells in some other part of the body. Dimercaptosuccinic acid (DMSA), dimercaptopropane sulfonate (DMPS), or ethylene diaminetetraacetic acid (EDTA) are names of chelates currently used.

A synthetic amino acid, which has been useful as a heavy metal chelating material, is EDTA (Ethylene Diamine Tetra-Acetic Acid). It is an FDA-approved treatment for lead, mercury, aluminum and cadmium removal, and has been used for lead chelating for over 50 years. EDTA also assists in restoring blood vessels jammed with calcium and arterial plaque. Basically EDTA is non-toxic and has few noticeable side effects. Unfortunately, it can also chelate necessary minerals and other elements from the body, so the treatment should be supplemented with vitamins and minerals.

Although chelation is the only way to treat lead poisoning, it’s beneficial results on the bloodstream can be used to treat other medical conditions. In addition to being the only way to treat lead poisoning, it removes unwanted metals, mineral deposits, calcium-based plaques and chemical poisons. Because of this, people with atherosclerosis (narrowing of the arteries by plaque deposits) and arteriosclerosis (hardening of the arteries and diabetes may also benefit.

For obvious reasons, double-blind studies have never been done to prove or disprove clinical benefits from bypass surgery or balloon angioplasty. The effectiveness of EDTA chelation therapy has been clinically proven to the same extent as bypass surgery and angioplasty, or more so, as established in data from the clinical studies published in the textbook of EDTA Chelation Therapy by Cranton.

A complete program of chelation therapy involves dietary changes, away from highly refined and processed foods. The use of nonprescription nutritional supplements is emphasized, more than expensive and highly profitable drugs patented and marketed by the pharmaceutical industry. Chelation therapy is performed in doctors’ offices, without the need for hospitals, surgeons, cardiologists and the large team of health professionals who profit greatly in dollars and reputation from the $6 billion per year bypass surgery and balloon angioplasty. It is a well-proven therapy and has been performed on more people than have received bypass surgery.

The most frequent criticism leveled by critics of non-traditional and alternative medical therapies is that new treatments are “unproven” because randomized, double-blind, controlled studies have not yet been done to prove effectiveness. Those criticisms ignore the fact that most medical procedures routinely performed in the practice of medicine are also unproven using those same criteria.

With 800,000 people per year dying in the United States alone from arteriosclerosis and its complications, despite the best of high-technology hospital and surgical care that is available, it is imperative that the public be given the option to receive EDTA chelation therapy. It would be senseless to continue to deny a therapy, which has the potential to greatly reduce long-term medical expenditures by reducing the need for far more expensive hospitalization, surgery or angioplasty. Savings to medical insurance companies with resulting reduction in insurance premiums could be great.

How about the improvement in quality of life?

Chelation patients have a tremendous increase in their expected life, although the chelation doctors are reluctant to admit it. It turns out that intravenous chelation therapy greatly reduces the risk of cancer as well as further heart disease. The chelation treatment deals with basic sources of all illness — the tiny particles of metal, which accumulate over time and which greatly, increase the production of free radicals in the body. As the interior source of free radical production is reduced, by more than one million times, the acceleration of aging stops and people generally feel much younger.

When the toxic metals are removed from the body by intravenous chelation therapy, billions and billions of free radicals are prevented from being created because the metals are now gone. When they exist in the body, they encourage a huge production of free radicals.

So, immediately all that poison being produced in the body STOPS.

The major causes of death in this country at present are heart disease and cancer. These can be reversed and prevented.

What chelation handles is the damage caused by free radicals; the therapeutic benefit of the chelating substance in reducing free radical activity and even reversing damage that had been done by those free radicals is astounding.

This article provides information for the education of the individual, and is not supposed to be taken as medical recommendations for the reader. Only a qualified health practitioner can give medical advice.

You can live healthier, longer – find out how at the Angel Longevity Medical Center